On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Innate Pharma's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€1.6M · 1 project
- Horizon 2020€183k · 1 project
- Erasmus+ (ERASMUS+)€0 · 1 project
Projects
3 EU-funded projects, newest first. Each links to the official record.
- CIVIS2Associated partner
CIVIS a European Civic University
Erasmus+ (ERASMUS+) · 2022–2026 · Project on the EU portal ↗
- MATURE-NKPartner
MAnufacturing of TUmour-REactive Natural Killer cells
Horizon 2020 · 2018–2022 · Project on CORDIS ↗
€183ktheir share - TUMADORPartner
Development of very promising humanized therapeutic mAbs efficiently neutralizing a novel immunosuppressive pathway involved in a wide range of cancers
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€1.6Mtheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Universite de LausanneSwitzerland · 2 shared projects
- Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 1 shared project
- The Hebrew University of JerusalemIsrael · 1 shared project
- Eberhard Karls Universitaet TuebingenGermany · 1 shared project
- Universita Degli Studi di Roma la SapienzaItaly · 1 shared project
- Ruprecht-Karls-Universitaet HeidelbergGermany · 1 shared project
- Institut PasteurFrance · 1 shared project
- Stockholms UniversitetSweden · 1 shared project
- University of GlasgowUnited Kingdom · 1 shared project
- Universidad Pompeu FabraSpain · 1 shared project
- Universite Libre de BruxellesBelgium · 1 shared project
- Medizinische Universitaet WienAustria · 1 shared project
- Universitat BaselSwitzerland · 1 shared project
- Ethniko Kai Kapodistriako Panepistimio AthinonGreece · 1 shared project
- Stockholm Exergi ABSweden · 1 shared project
- Universite D'Aix MarseilleFrance · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- business and management
- cells technologies
- drug discovery
- enzymes
- immunotherapy
- oncology
- personalized medicine
- pharmaceutical drugs
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗